Anal dysplasia involves the abnormal, unchecked cellular growth within the delicate mucosal lining of the anal canal, a condition heavily correlated with persistent, high-risk HPV infections and systemic immunosuppression.
Because this condition is largely asymptomatic in its earliest, most treatable stages, highly specialized clinical screening is a critical necessity. Dr. Farabi utilizes advanced cytological swabs (often referred to as anal Pap smears) to accurately detect the initial, microscopic cellular abnormalities.
When dysplasia is confirmed through pathology, we deploy highly precise, minimally invasive clinical interventions—such as topical antineoplastic therapies or targeted tissue ablation techniques—to eradicate the abnormal cells completely while meticulously preserving the healthy surrounding sphincter tissue.
Our rigorous post-treatment surveillance protocols are specifically designed to monitor relentlessly for any sign of recurrence, providing you with continuous, uncompromising protection against the devastating development of anal cancer.
